The HFpEF Drug Discovery and Development Summit 2022 | Digital Event is the first industry specific event dedicated to hfpef drug discovery & development.
The HFpEF Drug Discovery and Development Summit 2022 | Digital Event covers topics such as:
- The relationship of other comorbidities with HFpEF, with AstraZeneca and Novo Nordisk providing a holistic overview of patient health
- The outcomes of EMPEROR-Preserved with Boehringer Ingelheim to set up future trials for success
- Common mistakes biopharma make when exploring new therapeutic targets and learn how to avoid them with Dr Sheldon Litwin to understand how to design & execute a foolproof plan to successfully identify & validate new HFpEF patients
- Next-Generation Regulatory Genome Targets for Cardiac Fibrosis and other emerging therapeutics with HAYA Therapeutics to revive your therapeutic approach and treat HFpEF more successfully
- Current evaluations for quality of life for HFpEF patients and the major impact of fine-tuning this definition alters the drug development industry
